Articles
-
Read External ArticleSpecialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says
Evidence-Based Oncology interviews our CMO about mismatches between drug costs and efficacy.
-
Read External ArticleThe Mainstreaming of Targeted Lung Cancer Treatment
Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.
-
Read ArticleHealth Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals
Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.
-
Read ArticleSpecialty Pharmacies Grapple with Assessing Costs and Value of Oncology Therapies
Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.
-
Read ArticleEvolent Health, Parent Company of New Century Health, Announces Agreement to Acquire Vital Decisions
The addition of Vital Decisions’ specialized patient engagement services expected to position New Century Health to accelerate growth, improve patient care quality and increase margins.
-
Read ArticleHitting the Brakes on Fast-Tracked Drugs
The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.
-
Read ArticleTop Takeaways from the 2021 ASCO Annual Meeting
Our chief medical officer highlights noteworthy research and results from clinical oncology's premier event.
-
Read ArticleNew Century Health Supports Neighborhood Health Plan of Rhode Island with Comprehensive Oncology Management Services
New Century Health, a national leader in specialty care management, is proud to provide comprehensive oncology specialty management services to Neighborhood Health Plan of Rhode Island.
-
Watch VideoCMO Dr. Andrew Hertler Reacts to the FDA's Recent ODAC Meeting
New Century Health CMO, Dr. Andrew Hertler, shares his thoughts on the recent FDA meetings to review the merits of approved cancer drugs.
-
Read External ArticleA now-or-never moment for telehealth?
Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.
-
Read ArticleTraditional UM Programs Can't Move the Needle in Cardiology Care. Here's What Does.
Senior Medical Director Fernando Villacian lays out the key tenets of an effective cardiovascular management program.
-
Read External ArticleCardiovascular Clinical Pathways Program at New Century Health
Our senior medical director speaks with Journal of Clinical Pathways about preventing inappropriate use in cardiology.
-
Read ArticleNew Century Health Reports Year of Record Growth and Clinical Innovation in 2020
New Century Health announced that 2020 was the largest membership growth year in the 19-year history of the company.
-
Read ArticleCan Clinical Pathways Help Combat Health Care Disparities?
A new research effort aims to gauge whether certain groups of patients receive high-value therapies at lower rates than others.
-
Read ArticleA Redesigned Prior Authorization is Needed in Oncology. Here's How.
Payer strains now top the list of stressors facing oncologists, with prior authorization as the most-cited source of that payer stress.
-
Read ArticleEvolent Health, Parent Company of New Century Health, Names Kim Keck To Board of Directors
Evolent Health, Parent Company of New Century Health, Names Kim Keck to Board of Directors. Announces Cheryl Scott to Serve as Lead Independent Director.
-
Read ArticlePathways, Portals and Persuasion: Reining in an Overused Cancer Agent
NCH's approach to more appropriate use of myeloid growth factor provides a playbook for how to change prescribing patterns.
-
Read ArticleExperts and Execs Weigh In: Oncology Care in 2021 and Beyond
New Century Health recently convened health plan executives, industry experts and oncologists from across the nation to discuss the confluence of forces shaping oncology care in 2021 and beyond.
-
Read ArticleNew Century Health to Support Florida Blue Medicare with Comprehensive Oncology Management Services
The company will leverage New Century Health’s oncology specialty management program to help ensure its more than 125,000 Medicare Advantage members receive high-quality cancer care.
-
Read External ArticleOncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping
-
Loading More...
